
Stelis Biopharma’s CDMO partner receives approval for a key ANDA from the USFDA
Stelis Biopharma is pleased to announce that its CDMO partner has received ap
Stelis Biopharma is pleased to announce that its CDMO partner has received ap
Stelis Biopharma Limited, the biologics arm of Strides Pharma Science Limited
Stelis Biopharma, the biologics arm of Strides Pharma Science announced that
January 2021 In 2020 the Coronavirus pandemic has, unsurprisingly, proved to
A new CEO’s observations on managing a fast-growing, fully integrated biophar
This phase sees the CDMO start work on installing two 2,000-L single-use bior
State-of-the-art process and analytical development facilities for small-scal
Integrated state-of-the-art manufacturing facility leverages microbial and ma
A multipurpose facility with an ability to cater to multiple vaccine types in
A company that provides insurance and investment-related products and service